HRT Financial’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,869
Closed -$362K 5027
2026
Q1
$362K Sell
10,869
-58,497
-84% -$2.45M ﹤0.01% 2740
2025
Q4
$3.14M Sell
69,366
-417
-0.6% -$15.3K 0.01% 1017
2025
Q3
$2.12M Buy
69,783
+61,704
+764% +$1.9M 0.01% 1115
2025
Q2
$237K Sell
8,079
-12,768
-61% -$382K ﹤0.01% 1986
2025
Q1
$728K Sell
20,847
-121,921
-85% -$4.83M ﹤0.01% 1278
2024
Q4
$6.36M Sell
142,768
-23,642
-14% -$1.06M 0.03% 328
2024
Q3
$7.25M Buy
+166,410
New +$6.27M 0.04% 314
2024
Q2
Sell
-20,869
Closed -$610K 2850
2024
Q1
$610K Buy
+20,869
New +$633K ﹤0.01% 1152
2022
Q2
Sell
-7,350
Closed -$951K 3498
2022
Q1
$951K Sell
7,350
-5,540
-43% -$798K 0.01% 1113
2021
Q4
$2.33M Sell
12,890
-1,850
-13% -$321K 0.01% 588
2021
Q3
$2.19M Buy
14,740
+3,932
+36% +$602K 0.01% 682
2021
Q2
$1.64M Buy
+10,808
New +$1.5M 0.02% 727
2019
Q4
Sell
-4,070
Closed -$294K 1503
2019
Q3
$294K Buy
+4,070
New +$299K 0.01% 951

Other funds holding OMCL

HRT Financial's OMCL Position: Q2 2026 in Review

HRT Financial sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 10,869 shares — an estimated $362K sold.

HRT Financial first reported a position in OMCL in Q3 2019 and held it in 13 quarters. The position peaked at $7.25M in Q3 2024. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • HRT Financial reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 10,869 Omnicell shares in Q2 2026, an estimated $362K.
  • HRT Financial first reported a position in Omnicell in Q3 2019 and held it in 13 quarters.
  • HRT Financial's Omnicell position peaked at $7.25M in Q3 2024.
  • 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.